One limitation has been demonstrated in this study, in which an editing vector capable of rectifying one mutation would not be appropriate for patients holding various OTC mutations, plus the expression would not be quickly sufficient to remedy a hyperammonemia disorder. Here, OTC is linked to Hyperammonemia.